Anavex Life Sciences Announces ANAVEX®2-73 (Blarcamesine) Meets Primary and Secondary Endpoints in Placebo-Controlled U.S. Phase 2 Clinical Trial for the Treatment of Adult Patients with Rett Syndrome
https://www.anavex.com/anavex-life-...he-treatment-of-adult-patients-with-rett-syn/
-
- There are more pages in this discussion • 107 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$14.56 |
Change
0.380(2.68%) |
Mkt cap ! $1.806B | |||
| Open | High | Low | Value | Volume |
| $14.36 | $14.75 | $14.36 | $7.232M | 495.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 725 | $14.54 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.56 | 478 | 15 |
View Market Depth
| Last trade - 14.04pm 10/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |